Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives may cause hair loss in women.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Aging causes changes in the scalp that can affect hair growth and lead to older-looking hair in women.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

Non-obese women with hair loss have higher heart disease risk.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.